Bayforest Capital Ltd
Position in CRL — Charles River Laboratories International, Inc.
CIK 2048423
LONDON, X0
Position in CRL
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$356,060
+$319,835 QoQ
Shares Held
1,570
+647.6% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.33%
of 13F equity value
Holder Rank
#340
of 564 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CRL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Bayforest Capital Ltd holds $1,686,743 across 12 Diagnostics & Research names. CRL ranks #2 (21.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
721 | $361,480 | |
| 2 | CRL |
Charles River Laboratories International, Inc.
This page
|
1,570 | $356,060 | |
| 3 | MEDP |
Medpace Holdings, Inc.
|
595 | $315,106 | |
| 4 | LH |
Labcorp Holdings Inc.
|
585 | $163,800 | |
| 5 | NTRA |
Natera, Inc.
|
551 | $149,568 | |
| 6 | IDXX |
Idexx Laboratories Inc /De
|
223 | $117,396 | |
| 7 | A |
Agilent Technologies, Inc.
|
832 | $110,514 | |
| 8 | VCYT |
Veracyte, Inc.
|
725 | $42,579 |
All Filings in CRL
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $356,060 | 1,570 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $36,225 | 210 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $38,499 | 193 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $150,670 | 963 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $63,271 | 417 | Shares | Sole | 2025-07-28 | |
| No filing history on record for this holder in this stock. | ||||||